Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-009138

EVP, Chief Medical Officer acquired 5,650 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shah Jatin · EVP, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-05 Exercise or conversion : show line 1 in the form +5,650 49,875 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2021-02-05 Exercise or conversion : show line 2 in the form Restricted Stock Units −5,650 5,650 16,950 D
Loading xslF345X03/doc4.xml…